المؤلفون: Matsuda K; Research Center for Dynamic Living Systems, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan., Hirayama D; Research Center for Dynamic Living Systems, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan., Hino N; Research Center for Dynamic Living Systems, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan., Kuno S; Department of Pathology and Biology of Diseases, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan., Sakaue-Sawano A; Laboratory for Cell Function Dynamics, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan., Miyawaki A; Laboratory for Cell Function Dynamics, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan., Matsuda M; Research Center for Dynamic Living Systems, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.; Department of Pathology and Biology of Diseases, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.; Institute for Integrated Cell-Material Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan., Terai K; Department of Pathology and Biology of Diseases, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.

المصدر: Journal of cell science [J Cell Sci] 2023 Aug 15; Vol. 136 (16). Date of Electronic Publication: 2023 Aug 21.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Company of Biologists Country of Publication: England NLM ID: 0052457 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-9137 (Electronic) Linking ISSN: 00219533 NLM ISO Abbreviation: J Cell Sci Subsets: MEDLINE

مواضيع طبية MeSH: Signal Transduction* , Receptor, ErbB-2*/genetics , Receptor, ErbB-2*/metabolism, Animals ; Dogs ; Ligands ; Phosphorylation ; Genes, erbB ; Cell Proliferation/genetics ; Receptor, ErbB-3/genetics ; Receptor, ErbB-3/metabolism

المؤلفون: Piha-Paul SA; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA. spihapau@mdanderson.org., Tseng C; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA., Tran HT; Department of Thoracic, Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gao M; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA., Karp DD; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA., Subbiah V; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA., Tsimberidou AM; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA., Kawedia JD; Pharmacy Pharmacology Research, Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston, USA., Fu S; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA., Pant S; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yap TA; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA.; Department of Thoracic, Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Morris VK; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kee BK; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Blum Murphy M; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lim J; Pharmacy Clinical Programs, Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Meric-Bernstam F; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX, 77030, USA.; Department of Breast Surgical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.; The Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

المصدر: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2023 Aug; Vol. 92 (2), pp. 107-118. Date of Electronic Publication: 2023 Jun 14.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Proto-Oncogene Proteins p21(ras)*/genetics , Neoplasms*/drug therapy, Humans ; Middle Aged ; Antineoplastic Combined Chemotherapy Protocols ; Protein Kinase Inhibitors/adverse effects ; Genes, erbB ; Mutation ; ErbB Receptors/genetics ; Nausea/drug therapy ; Diarrhea/drug therapy ; Mitogen-Activated Protein Kinase Kinases ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism

المؤلفون: Xing L; Department of Radiation Oncology and Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, China., Wu G; Cancer Center, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Wang L; Department of Radiation Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China., Li J; Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Clinical College of Fujian Medical University, Fuzhou, China., Wang J; Department of Radiation Oncology, Zhengzhou University Cancer Hospital, Zhengzhou, China., Yuan Z; Department of Radiation Oncology, CyberKnife Center, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, China., Chen M; Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, China., Xu Y; Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, China., Fu X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Zhu Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Lu Y; Department of Thoracic Oncology, Huaxi Hospital, Sichuan University, Chengdu, China., Han C; Department of Thoracic Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Xia T; Department of Radiation Oncology, Air Force General Hospital, Beijing, China., Xie C; Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China., Li G; Department of Radiation Oncology, First Hospital of China Medical University, Shenyang, China., Ma S; Department of Oncology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China., Lu B; Department of Radiation Oncology, Guizhou Cancer Hospital, Guiyang, China., Lin Q; Department of Radiation Oncology, First Affiliated Hospital of Xiamen University, Xiamen, China., Zhu G; Department of Radiation Oncology, Beijing Cancer Hospital, Beijing, China., Qu B; Department of Radiation Oncology, PLA General Hospital, Beijing, China., Zhu W; Department of Radiation Oncology and Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, China., Yu J; Department of Radiation Oncology and Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, China. Electronic address: sdyujinming@126.com.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2021 Apr 01; Vol. 109 (5), pp. 1349-1358. Date of Electronic Publication: 2020 Nov 19.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/therapy , Genes, erbB* , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Lung Neoplasms*/therapy , Mutation*, Antineoplastic Agents/*administration & dosage , Chemoradiotherapy/*methods, Adult ; Aged ; Antineoplastic Agents/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; China ; Cisplatin/administration & dosage ; Cisplatin/adverse effects ; Confidence Intervals ; Drug Administration Schedule ; Epirubicin/administration & dosage ; Epirubicin/adverse effects ; Erlotinib Hydrochloride/administration & dosage ; Erlotinib Hydrochloride/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Progression-Free Survival ; Proportional Hazards Models ; Radiation-Sensitizing Agents/administration & dosage ; Radiation-Sensitizing Agents/adverse effects ; Radiotherapy ; Radiotherapy Dosage

SCR Protocol: PE regimen

المؤلفون: Noorani I; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK. in1@sanger.ac.uk.; Department of Neurosurgery, Addenbrookes Hospital, University of Cambridge, Hills Road, Cambridge, CB2 0QQ, UK. in1@sanger.ac.uk., de la Rosa J; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Choi YH; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.; Department of New Biology, DGIST, 333, Techno Jungang Daero, Hyeonpung-Myeon, Dalseong-Gun, Daegu, 42988, South Korea., Strong A; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Ponstingl H; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Vijayabaskar MS; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Lee J; Department of New Biology, DGIST, 333, Techno Jungang Daero, Hyeonpung-Myeon, Dalseong-Gun, Daegu, 42988, South Korea., Lee E; Department of New Biology, DGIST, 333, Techno Jungang Daero, Hyeonpung-Myeon, Dalseong-Gun, Daegu, 42988, South Korea., Richard-Londt A; Division of Neuropathology and Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, Mailbox 126, London, WC1N 3BG, UK., Friedrich M; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.; Department of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675, Munich, Germany., Furlanetto F; Department of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675, Munich, Germany., Fuente R; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Banerjee R; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Yang F; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Law F; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Watts C; Department of Neurosurgery, Addenbrookes Hospital, University of Cambridge, Hills Road, Cambridge, CB2 0QQ, UK.; Birmingham Brain Cancer Program, Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK., Rad R; Department of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675, Munich, Germany., Vassiliou G; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Kim JK; Department of New Biology, DGIST, 333, Techno Jungang Daero, Hyeonpung-Myeon, Dalseong-Gun, Daegu, 42988, South Korea., Santarius T; Department of Neurosurgery, Addenbrookes Hospital, University of Cambridge, Hills Road, Cambridge, CB2 0QQ, UK., Brandner S; Division of Neuropathology and Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, Mailbox 126, London, WC1N 3BG, UK., Bradley A; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK. abradley@sanger.ac.uk.

المصدر: Genome biology [Genome Biol] 2020 Jul 30; Vol. 21 (1), pp. 181. Date of Electronic Publication: 2020 Jul 30.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Validation Study

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100960660 Publication Model: Electronic Cited Medium: Internet ISSN: 1474-760X (Electronic) Linking ISSN: 14747596 NLM ISO Abbreviation: Genome Biol Subsets: MEDLINE

مواضيع طبية MeSH: DNA Transposable Elements* , Genes, erbB*, Central Nervous System Neoplasms/*genetics , ErbB Receptors/*genetics , Glioma/*genetics, Animals ; Carcinogenesis ; ErbB Receptors/metabolism ; Genomic Instability ; Humans ; Mice, Transgenic ; Molecular Targeted Therapy ; Mutagenesis, Insertional ; Neoplasms, Experimental ; Nerve Tissue Proteins ; Exome Sequencing

المؤلفون: Bredel M; Department of Radiation Oncology, O'Neal Comprehensive Cancer Center, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA., Kim H; Lineberger Comprehensive Cancer Center, University of Northern Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Bonner JA; Department of Radiation Oncology, O'Neal Comprehensive Cancer Center, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2022 Nov 04; Vol. 23 (21). Date of Electronic Publication: 2022 Nov 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Head and Neck Neoplasms*/drug therapy , Head and Neck Neoplasms*/genetics , Carcinoma, Squamous Cell*/drug therapy , Carcinoma, Squamous Cell*/genetics , Antineoplastic Agents*/pharmacology, Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Regulon ; Genes, erbB

المؤلفون: Soosanabadi M; Department of Medical Genetics, Semnan University of Medical Sciences, Semnan, Iran., Ghahfarokhi AM; Department of Cellular and Molecular Biology, Faculty of Life Sciences and Technology, Shahid Beheshti University, Tehran, Iran., Pourghazi F; Faculty of Medicine, Tehran University of Medical Science, Tehran, Iran., Ehtesham N; Department of Medical Genetics, Semnan University of Medical Sciences, Semnan, Iran., Mirfakhraie R; Department of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Atanesyan L; MRC-Holland BV, Amsterdam, the Netherlands., Keyhani E; Clinical Research Development Center of Rofeideh Rehabilitation Hospital, Tehran, Iran. keyhani.e@yahoo.com., Behjati F; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. fa.behjatii@gmail.com.; Sarem Fertility & Infertility Research Center (SAFIR), Sarem Women's Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran. fa.behjatii@gmail.com.; Sarem Cell Research Center (SCRC), Sarem Women's Hospital, Tehran, Iran. fa.behjatii@gmail.com.

المصدر: Molecular biology reports [Mol Biol Rep] 2022 Sep; Vol. 49 (9), pp. 8547-8553. Date of Electronic Publication: 2022 Jun 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/metabolism, Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Female ; Genes, erbB ; Humans ; Immunohistochemistry ; Ki-67 Antigen/metabolism ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/genetics ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/genetics ; Receptors, Progesterone/metabolism

المؤلفون: Prats C; Departament de Biologia Evolutiva, Ecologia i Ciències Ambientals, Facultat de Biologia, Universitat de Barcelona, Spain; Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Spain.; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.; Institut d'Investigació Biomèdica de Bellvitge, Hospital Duran i Reynals, L'Hospitalet de Llobregat, Barcelona, Spain., Fatjó-Vilas M; Departament de Biologia Evolutiva, Ecologia i Ciències Ambientals, Facultat de Biologia, Universitat de Barcelona, Spain; Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Spain.; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain., Penzol MJ; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, Madrid, Spain., Kebir O; INSERM, U1266, Laboratory 'Pathophysiology of psychiatric disorders', Institute of psychiatry and neurosciences of Paris, Paris, France.; GHU Psychiatrie et Neurosciences de Paris, Paris, France., Pina-Camacho L; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, Madrid, Spain., Demontis D; Department of Biomedicine, Aarhus University, Aarhus, Denmark; The Lundbeck Foundation Initiative for Integrative Psychiatric Research iPSYCH, Aarhus, Denmark., Crespo-Facorro B; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.; University Hospital Virgen del Rocio, IbiS Department of Psychiatry, School of Medicine, University of Sevilla, Sevilla, Spain., Peralta V; Gerencia de Salud Mental, Servicio Navarro de Salud-Osasunbidea, Pamplona, Navarra, Spain.; Instituto de Investigación Sanitaria de Navarra (IdiSNa), Pamplona, Navarra, Spain., González-Pinto A; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.; Psychiatry Service, University Hospital of Alava-Santiago, EMBREC, EHU/UPV University of the Basque Country, Kronikgune, Vitoria, Spain., Pomarol-Clotet E; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain., Papiol S; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.; Department of Psychiatry, University Hospital, Ludwig Maximilian University, Munich, Germany., Parellada M; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, Madrid, Spain., Krebs MO; INSERM, U1266, Laboratory 'Pathophysiology of psychiatric disorders', Institute of psychiatry and neurosciences of Paris, Paris, France.; University Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine Paris Descartes, Service Hospitalo-Universitaire, Centre Hospitalier Sainte-Anne, Paris, France., Fañanás L; Departament de Biologia Evolutiva, Ecologia i Ciències Ambientals, Facultat de Biologia, Universitat de Barcelona, Spain; Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Spain.; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.

المصدر: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry [World J Biol Psychiatry] 2022 Mar; Vol. 23 (3), pp. 208-218. Date of Electronic Publication: 2021 Aug 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 101120023 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1814-1412 (Electronic) Linking ISSN: 15622975 NLM ISO Abbreviation: World J Biol Psychiatry Subsets: MEDLINE

مواضيع طبية MeSH: Schizophrenia*/genetics , Autism Spectrum Disorder*/genetics , White Matter*, Humans ; Polymorphism, Single Nucleotide ; Genes, erbB ; Neuregulin-1/genetics

المؤلفون: Sarvari P; Max Planck Institute for Heart and Lung Research, Department of Developmental Genetics, Bad Nauheim, 61231, Germany., Rasouli SJ; Max Planck Institute for Heart and Lung Research, Department of Developmental Genetics, Bad Nauheim, 61231, Germany., Allanki S; Max Planck Institute for Heart and Lung Research, Department of Developmental Genetics, Bad Nauheim, 61231, Germany., Stone OA; Max Planck Institute for Heart and Lung Research, Department of Developmental Genetics, Bad Nauheim, 61231, Germany., Sokol AM; Max Planck Institute for Heart and Lung Research, Department of Developmental Genetics, Bad Nauheim, 61231, Germany; Max Planck Institute for Heart and Lung Research, Biomolecular Mass Spectrometry, Bad Nauheim, 61231, Germany., Graumann J; Max Planck Institute for Heart and Lung Research, Department of Developmental Genetics, Bad Nauheim, 61231, Germany; Max Planck Institute for Heart and Lung Research, Biomolecular Mass Spectrometry, Bad Nauheim, 61231, Germany., Stainier DYR; Max Planck Institute for Heart and Lung Research, Department of Developmental Genetics, Bad Nauheim, 61231, Germany. Electronic address: Didier.Stainier@mpi-bn.mpg.de.

المصدر: Developmental biology [Dev Biol] 2021 Dec; Vol. 480, pp. 1-12. Date of Electronic Publication: 2021 Aug 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0372762 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-564X (Electronic) Linking ISSN: 00121606 NLM ISO Abbreviation: Dev Biol Subsets: MEDLINE

مواضيع طبية MeSH: Myocardium/*metabolism , Ubiquitin-Protein Ligases/*metabolism, Animals ; Cell Proliferation/genetics ; Endocardium/metabolism ; Endothelium/metabolism ; Gene Expression/genetics ; Gene Expression Regulation/genetics ; Genes, erbB/genetics ; Heart/physiology ; Heart Ventricles/metabolism ; Hedgehog Proteins/metabolism ; Morphogenesis/genetics ; Myocardial Contraction ; Myocytes, Cardiac/metabolism ; Organogenesis/genetics ; Receptors, Notch/genetics ; Receptors, Notch/metabolism ; Signal Transduction/genetics ; Ubiquitin-Protein Ligases/genetics ; Zebrafish/genetics ; Zebrafish/metabolism ; Zebrafish Proteins/genetics ; Zebrafish Proteins/metabolism

المؤلفون: Laplace-Builhé B; IRMB, Univ Montpellier, INSERM, Montpellier, France., Barthelaix A; IRMB, Univ Montpellier, INSERM, Montpellier, France., Assou S; IRMB, Univ Montpellier, INSERM, Montpellier, France., Bohaud C; IRMB, Univ Montpellier, INSERM, Montpellier, France., Pratlong M; MGX, BCM, Univ Montpellier, CNRS, INSERM, Montpellier, France., Severac D; MGX, BCM, Univ Montpellier, CNRS, INSERM, Montpellier, France., Tejedor G; IRMB, Univ Montpellier, INSERM, Montpellier, France., Luz-Crawford P; Laboratorio de Inmunología Celular y Molecular, Facultad de Medicina, Universidad de los Andes, Santiago, Chile.; IMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Santiago, Chile., Nguyen-Chi M; LPHI, Univ Montpellier, CNRS, Montpellier, France., Mathieu M; IRMB, Univ Montpellier, INSERM, Montpellier, France., Jorgensen C; IRMB, Univ Montpellier, INSERM, Montpellier, France.; CHU Montpellier, Montpellier, France., Djouad F; IRMB, Univ Montpellier, INSERM, Montpellier, France. farida.djouad@inserm.fr.

المصدر: Nature communications [Nat Commun] 2021 Nov 03; Vol. 12 (1), pp. 6336. Date of Electronic Publication: 2021 Nov 03.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Animal Fins/*metabolism , Genes, erbB/*genetics , Macrophages/*metabolism , Neural Crest/*metabolism , Neuregulin-1/*metabolism , Regeneration/*physiology , Signal Transduction/*physiology, Animals ; Cell Proliferation ; Forkhead Transcription Factors/metabolism ; Gene Expression Regulation, Developmental ; Larva ; Neuregulin-1/genetics ; Regeneration/genetics ; Signal Transduction/genetics ; Stem Cells ; Zebrafish/genetics ; Zebrafish/metabolism ; Zebrafish Proteins/genetics ; Zebrafish Proteins/metabolism

المؤلفون: Tran HT; University of Texas MD Anderson Cancer Center, Houston, TX., Lam VK; University of Texas MD Anderson Cancer Center, Houston, TX., Elamin YY; University of Texas MD Anderson Cancer Center, Houston, TX., Hong L; University of Texas MD Anderson Cancer Center, Houston, TX., Colen R; University of Texas MD Anderson Cancer Center, Houston, TX., Elshafeey NA; University of Texas MD Anderson Cancer Center, Houston, TX., Hassan ISA; University of Texas MD Anderson Cancer Center, Houston, TX., Altan M; University of Texas MD Anderson Cancer Center, Houston, TX., Blumenschein GR; University of Texas MD Anderson Cancer Center, Houston, TX., Rinsurongkawong W; University of Texas MD Anderson Cancer Center, Houston, TX., Rivera MJ; University of Texas MD Anderson Cancer Center, Houston, TX., Vasquez ME; University of Texas MD Anderson Cancer Center, Houston, TX., Carter BW; University of Texas MD Anderson Cancer Center, Houston, TX., Byers LE; University of Texas MD Anderson Cancer Center, Houston, TX., Tsao AS; University of Texas MD Anderson Cancer Center, Houston, TX., Gibbons DL; University of Texas MD Anderson Cancer Center, Houston, TX., Fossella F; University of Texas MD Anderson Cancer Center, Houston, TX., Glisson BS; University of Texas MD Anderson Cancer Center, Houston, TX., Zhang J; University of Texas MD Anderson Cancer Center, Houston, TX., Heymach JV; University of Texas MD Anderson Cancer Center, Houston, TX.

المصدر: JCO precision oncology [JCO Precis Oncol] 2021 Aug 05; Vol. 5. Date of Electronic Publication: 2021 Aug 05 (Print Publication: 2021).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: eCollection Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung/*blood , Circulating Tumor DNA/*blood , Genes, erbB/*genetics , Lung Neoplasms/*blood , Protein Kinase Inhibitors/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/genetics ; Drug Resistance, Neoplasm/genetics ; ErbB Receptors/genetics ; Female ; Gene Frequency ; Genomics ; High-Throughput Nucleotide Sequencing ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Male ; Middle Aged ; Mutation ; Progression-Free Survival ; Retrospective Studies